sestd1 Antibody

What is SESTD1 and why is it significant for cellular research?

SESTD1, also known as Protein Solo or SEC14 domain and spectrin repeat-containing protein 1, is a multifunctional protein that contains a SEC14-like lipid binding domain and two spectrin domains (Spec1 and Spec2) . The protein enables phosphatidylinositol-3,4-bisphosphate binding activity and phospholipid binding activity, and is involved in negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel .

SESTD1 has gained research significance because:

• It interacts with TRPC4 and TRPC5 channels via their calmodulin and inositol 1,4,5-trisphosphate receptor-binding (CIRB) domains

• It binds several phospholipid species (phosphatidylinositol monophosphates, diphosphates, and phosphatidic acid) in a calcium-dependent manner

• It has been identified as a novel risk gene for lithium-responsive bipolar disorder

• It plays a role in the planar cell polarity (PCP) pathway during embryonic development

Understanding SESTD1's function is important for research in calcium signaling, neuropsychiatric disorders, and developmental biology.

What are the optimal applications for SESTD1 antibodies in experimental research?

SESTD1 antibodies have been validated for several key laboratory applications:

For optimal results, researchers should:

• Validate antibody specificity using knockout/knockdown controls

• Include appropriate blocking steps to minimize background

• Optimize fixation methods based on subcellular localization (SESTD1 localizes to intermediate filament cytoskeleton and colocalizes with calcium channel complexes)

How can I validate the specificity of SESTD1 antibodies in my experimental system?

Validating SESTD1 antibody specificity is crucial for reliable results. Recommended approaches include:

Positive Controls:

• Use tissues with known high SESTD1 expression such as thalamus, brain, and vascular tissues

• Human cell lines such as HepG2, MCF-7, and Daudi cells show detectable SESTD1 expression

• Mouse and rat brain and testis tissue lysates show consistent SESTD1 expression

Negative Controls:

• Implement siRNA knockdown of SESTD1 (85% reduction in protein levels has been achieved in previous studies)

• Pre-absorption with the immunizing peptide should eliminate specific signals

• Include secondary antibody-only controls to assess non-specific binding

Validation Methods:

• Western blot should show a specific band at approximately 79 kDa

• Flow cytometry should show specific shifts compared to isotype controls

• For immunohistochemistry, compare staining patterns with published literature and verify absence of signal in knockdown/knockout samples

A comprehensive validation strategy increases confidence in experimental results and helps troubleshoot potential issues with antibody cross-reactivity.

What expression patterns of SESTD1 should researchers expect across different tissues?

SESTD1 shows a distinct expression pattern that researchers should consider when designing experiments:

Tissue Expression Profile:

• Highest expression in thalamus (approximately 2.5% of housekeeping gene RPL37a expression levels)

• Relatively high expression throughout brain tissues

• Significant expression in vasculature, including endothelial and smooth muscle cells

• Moderate to low expression across other human tissues

Cellular Localization:

• Present in intermediate filament cytoskeleton

• Colocalizes with calcium channel complexes

• May associate with β-catenin at adherens junctions

Species Conservation:

• Expressed in human, mouse, and rat tissues with conserved functions

• Western blot analysis confirms expression in multiple species at the expected molecular weight

Understanding this expression pattern helps researchers select appropriate experimental tissues and interpret immunostaining results correctly. For tissues with lower expression levels, more sensitive detection methods may be required.

What methodological approaches are effective for studying SESTD1's interaction with TRPC channels using antibodies?

Investigating SESTD1's interaction with TRPC channels requires specialized approaches:

Co-immunoprecipitation (Co-IP) Optimization:

• Use mild detergent conditions (1% Triton X-100, 150 mM NaCl, 50 mM Tris-HCl, pH 7.4 with protease inhibitors)

• Pre-clear lysates to reduce non-specific binding

• For TRPC4/5 interaction studies, target the CIRB domain region (amino acids 700-728 of TRPC4)

• Incubate with anti-TRPC4 or anti-GFP antibodies overnight at 4°C for optimal complex formation

Proximity Ligation Assay (PLA):

• Useful for confirming protein interactions in situ

• Requires validated antibodies from different species against SESTD1 and TRPC4/5

• Fixation must preserve membrane protein complexes (4% paraformaldehyde is recommended)

FRET/BRET Analysis:

• For live-cell interaction studies, tag SESTD1 and TRPC proteins with appropriate fluorophore pairs

• Control for proper folding and trafficking of fusion proteins

• Calcium fluctuations may influence interaction dynamics

Protein Domain Mapping:

• For detailed interaction studies, use constructs expressing the Spec1 domain of SESTD1, which mediates binding to TRPC channels

• The CIRB domain of TRPC4/5 is critical for interaction with SESTD1

When analyzing results, consider that SESTD1 knockdown significantly reduces receptor-mediated activation of TRPC5 without affecting receptor signaling pathways upstream of TRPC5 , suggesting a specific regulatory role at the channel level.

How can researchers effectively use SESTD1 antibodies to investigate its phospholipid-binding properties?

Studying SESTD1's phospholipid-binding function requires specialized techniques:

Lipid Overlay Assay Protocol:

• Spot various phospholipids (phosphatidylinositol monophosphates, diphosphates, phosphatidic acid, phosphatidylcholine, phosphatidylserine) onto nitrocellulose membranes

• Block membranes with appropriate blocking buffer

• Incubate with purified SESTD1 protein

• Detect bound SESTD1 using validated anti-SESTD1 antibodies

• Compare binding patterns in the presence and absence of calcium (Ca²⁺-dependent binding has been observed)

Calcium Dependency Considerations:

• Include parallel assays with varying Ca²⁺ concentrations (0-1 mM)

• SESTD1 shows increased binding to phosphatidylinositol diphosphates in the presence of calcium

• Controls should include other lipid-binding domains with known calcium dependencies

Domain-Specific Analysis:

• The SEC14 domain mediates phospholipid binding

• Generate and purify recombinant SEC14 domain for direct binding studies

• Use domain-specific antibodies to assess binding of different SESTD1 domains

Liposome Binding Assays:

• Prepare liposomes with different phospholipid compositions

• Incubate with purified SESTD1

• Separate bound and unbound fractions by centrifugation

• Analyze bound SESTD1 by Western blot using anti-SESTD1 antibodies

Results interpretation should consider that SESTD1 binds specifically to phosphatidylinositol monophosphates, diphosphates, and phosphatidic acid, but not to less polar lipids like phosphatidylcholine, phosphatidylserine, and phosphatidylinositol .

What experimental design approaches are recommended for investigating SESTD1's role in calcium signaling pathways?

SESTD1's function in calcium signaling can be studied using carefully designed experiments:

Calcium Imaging Protocol:

• Load cells with calcium-sensitive dyes like Fura-2

• Establish baseline calcium levels in resting cells

• Stimulate with agonists that activate TRPC channels (carbachol, trypsin)

• Compare calcium responses in control vs. SESTD1 knockdown cells

• Calculate area under curve (AUC) for comprehensive analysis of calcium transients

siRNA Knockdown Design:

• Target SESTD1-specific sequences with validated siRNAs (previous studies achieved ~85% reduction)

• Include non-targeting siRNA controls and mock-transfected cells

• Verify knockdown efficiency by Western blot with anti-SESTD1 antibodies

• Assess effects on both calcium release (in Ca²⁺-free solution) and calcium entry components

Channel Function Assessment:

• Patch-clamp electrophysiology to directly measure TRPC4/5 channel currents

• Compare current-voltage relationships in control vs. SESTD1-depleted cells

• Analyze both basal and receptor-stimulated channel activity

Data Analysis Framework:

• Separate calcium release and calcium entry components temporally

• Evaluate t > 120s time points when contribution of Ca²⁺ release is negligible

• Calculate total Ca²⁺ changes from area under fluorescence curves

• Apply appropriate statistical tests (ANOVA with post-hoc analysis)

Published results show that SESTD1 knockdown significantly reduces TRPC5-mediated Ca²⁺ influx without affecting receptor-induced Ca²⁺ release, indicating that SESTD1 specifically regulates channel function rather than upstream signaling pathways .

What approaches should be used to study SESTD1's role in developmental processes and genetic interactions?

Investigating SESTD1's developmental functions requires specialized genetic and developmental biology techniques:

Genetic Interaction Studies:

• Generate compound mutants (e.g., Sestd1+/- with Vangl2+/- or Dact1+/-)

• Assess reciprocal rescue interactions between mutant alleles

• Compare phenotypes of single and double mutants quantitatively

• Use SESTD1 antibodies to verify protein levels in different genotypes

Knockout Mouse Analysis Protocol:

• Generate Sestd1 knockout mice using homologous recombination in ES cells

• Establish mouse lines with constitutive null alleles through Cre-mediated excision

• Verify protein loss by immunoblot with anti-SESTD1 antibodies

• Perform detailed phenotypic analysis focusing on posterior malformations

• Compare with phenotypes of other PCP pathway mutants (Dact1, Vangl2)

Planar Cell Polarity Assessment:

• Analyze tissue organization in epithelial structures

• Use SESTD1 antibodies in conjunction with other PCP component antibodies

• Assess subcellular localization and asymmetric distribution

• Quantify cell orientation and polarity defects

Rho GTPase Activity Measurement:

• SESTD1 cooperates with Dact1 to activate the PCP effector Rho GTPase

• Use pull-down assays with GST-Rhotekin to measure active Rho

• Compare Rho activation in wild-type vs. Sestd1-null tissues

• Verify results with pharmacological Rho pathway inhibitors

Research has shown that Sestd1 knockout mice display posterior malformations identical to Dact1 knockout mice, and double mutants show the same spectrum of phenotypes as single mutants, suggesting they function in a unitary pathway .

What methodological considerations are important when using SESTD1 antibodies to study its potential role in psychiatric disorders?

Investigating SESTD1's role in psychiatric disorders such as lithium-responsive bipolar disorder requires careful experimental design:

Case-Control Association Studies:

• Compare SESTD1 expression in patient vs. control samples using validated antibodies

• Correlate with clinical measures of lithium responsiveness in bipolar disorder

• Consider genetic variation (e.g., rs116323614) when interpreting expression differences

• Use standardized patient assessment scales for lithium response classification

Protein Expression Analysis Protocol:

• Collect post-mortem brain tissues or patient-derived peripheral samples

• Extract proteins using gentle lysis buffers to preserve interactions

• Perform Western blot with anti-SESTD1 antibodies

• Quantify expression levels relative to housekeeping proteins

• Correlate with genotype at rs116323614 locus

Functional Cellular Models:

• Generate cellular models using patient-derived iPSCs

• Differentiate into neurons and assess SESTD1 expression/localization

• Evaluate calcium signaling in cells with different SESTD1 variants

• Test lithium effects on SESTD1 protein interactions and phospholipid binding

Phospholipid Analysis:

• SESTD1 encodes a protein involved in regulation of phospholipids

• Phospholipids have been strongly implicated as lithium treatment targets

• Compare phospholipid profiles in samples with different SESTD1 variants

• Assess SESTD1-phospholipid interactions with and without lithium treatment

A genome-wide association study identified a significant association between an intronic SNP (rs116323614) in SESTD1 and risk for lithium-responsive bipolar disorder, with an estimated SNP heritability of 0.25-0.29 . This suggests that SESTD1 may contribute to the biological mechanisms underlying lithium response.

What technical controls and troubleshooting strategies are crucial when working with SESTD1 antibodies in complex experimental systems?

Successfully working with SESTD1 antibodies in complex systems requires rigorous controls and troubleshooting approaches:

Essential Experimental Controls:

Troubleshooting Strategies for Common Issues:

• High Background in Immunofluorescence:

  • Increase blocking time (5% non-fat milk/TBS for 1.5 hours at room temperature)

  • Optimize antibody concentration (start with 0.5 μg/ml for most applications)

  • Use longer wash steps (TBS-0.1% Tween, 3 times for 5 minutes each)

• Multiple Bands in Western Blot:

  • Optimize gel percentage (5-20% SDS-PAGE recommended)

  • Adjust running conditions (70V stacking/90V resolving for 2-3 hours)

  • Use fresh protease inhibitors to prevent degradation

  • Verify expected band size (79 kDa for SESTD1)

• Weak Signal in Co-immunoprecipitation:

  • Modify lysis conditions to preserve protein-protein interactions

  • Crosslink proteins before lysis for transient interactions

  • Try different epitope tags (FLAG-SESTD1 and HA-TRPC constructs work well)

  • Increase incubation time (overnight at 4°C recommended)

• Inconsistent Results in Functional Assays:

  • Standardize cell densities for calcium imaging experiments

  • Control for receptor expression levels when studying TRPC channel activation

  • Account for cell cycle effects (SESTD1 may have cell cycle-dependent functions)

  • Verify that Fura-2 loading is consistent across experimental conditions